Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of pentoxifylline in COVID-19
IRCT20210623051677N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in coronavirus disease 2019 (COVID-19) and hypoxia, sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started Aug 2021; status: completed.
02
Drugs
pentoxifylline
03
Conditions
coronavirus disease 2019 (COVID-19)hypoxia
Beyond the preview
Go deeper on IRCT20210623051677N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210623051677N1.